Malignant Peritoneal Neoplasm Completed Phase 2 Trials for Pazopanib (DB06589)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00281632A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian CancerTreatment